About Ranbaxy Laboratories
Ranbaxy Laboratories is a Healthcare company based in Gurugram (India) founded in 1961, and was acquired by Sun Pharma in April 2014. It operates as an a well-diversified pharma company manufacturing marketing range of pharmaceutical products. The company has 1 employees. Its Indian entity Ranbaxy Laboratories Ltd reported revenue of ₹1.3 Lakh. Its focus areas include Traditional Pharmaceuticals.
Company details
Ranbaxy Laboratories was founded in 1961 and operates in the pharmaceutical sector from Gurugram, India. Generic medicines, branded generics, active pharmaceutical ingredients, and intermediates are produced across manufacturing facilities in 11 countries. Operations extend to 49 countries with customer reach in about 125 nations, covering chronic and acute therapeutic areas. Research and development efforts focus on novel drug delivery systems and new chemical entities for infectious, metabolic, and oncology segments.
- Headquarters Gurugram, India
- Employees 1
- Stage Acquired
- SectorsHealthcare
- Website ranbaxy.com
- Social LinkedIn
- Acquired by Sun Pharma (Apr 2014)
- Legal Name Ranbaxy Laboratories Ltd
- Date of Incorporation 16 Jun, 1961
- Jurisdiction Mohali, Punjab, India
- Annual Revenue₹1.3 Lakh
FY 2014 · +5% YoY
- Latest Funding Round$373.34K (USD), Grant
Mar 2008
- InvestorsSun Pharma
& 1 more
- Employee Count1
- Acquired bySun Pharma
(Apr 2014)
Associated legal entities of Ranbaxy Laboratories
Ranbaxy Laboratories operates through Ranbaxy Laboratories Ltd, a listed company (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2014) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ranbaxy Laboratories Ltd Listed CIN L24231PB1961PLC003747 | Amalgamated | 16 Jun 1961 | Mohali, Punjab | ₹0.0 Cr | – | 9 | View details |
Funding Insights of Ranbaxy Laboratories
- Total Rounds 1
- Last Round Grant — $373,344
- First Round $373,344
(Mar 2008)
- Investors Count 1
All 1 funding rounds of Ranbaxy Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2008 | $373,344 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Ranbaxy Laboratories
Ranbaxy Laboratories has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Sun Pharma and Department of Biotechnology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotechnology research, guidelines, and funding by the Government of India. | 1986 | dbtindia.gov.in | Delhi, India | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | sunpharma.com | Mumbai, India |
Investor details for Ranbaxy Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ranbaxy Laboratories Ltd (Ranbaxy Laboratories)
Ranbaxy Laboratories Ltd is the primary company behind Ranbaxy Laboratories. The board of Ranbaxy Laboratories Ltd currently have 9 directors; the longest-serving is Sushil Kumar Patawari, appointed in 1995. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sushil Kumar Patawari DIN 00112936 | Company Secretary | 21 Sep 1995 | 31 yrs | Ranbaxy Laboratories Ltd |
| Takashi Shoda DIN 02436813 | Director | 19 Dec 2008 | 17 yrs 10 mo | Ranbaxy Laboratories Ltd |
| Percy Keku Shroff DIN 02143003 | Director | 27 Mar 2009 | 17 yrs 6 mo | Ranbaxy Laboratories Ltd |
| Rajesh Viren Shah DIN 00021752 | Director | 29 May 2009 | 17 yrs 4 mo | Ranbaxy Laboratories Ltd |
| Tsutomu Une DIN 02439401 | Director | 10 May 2010 | 16 yrs 5 mo | Ranbaxy Laboratories Ltd |
| Akihiro Watanabe DIN 02439360 | Director | 09 May 2011 | 15 yrs 5 mo | Ranbaxy Laboratories Ltd |
| Arun Sawhney DIN 01929668 | Managing Director | 09 May 2011 | 15 yrs 5 mo | Ranbaxy Laboratories Ltd |
| Anthony Hugh Wild DIN 02454431 | Director | 09 May 2011 | 15 yrs 5 mo | Ranbaxy Laboratories Ltd |
| Kazunori Hirokawa DIN 03562763 | Director | 09 May 2012 | 14 yrs 5 mo | Ranbaxy Laboratories Ltd |
Financials of Ranbaxy Laboratories
Figures of Ranbaxy Laboratories Ltd, the primary company behind Ranbaxy Laboratories, for FY 2014. Revenue was ₹1.3 Lakh (+5% year on year).
- ₹1.3 LakhRevenue · FY 2014 · +5% YoY
- ₹213 CrPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Ranbaxy Laboratories Ltd are on its company page.
Detailed financial statements for Ranbaxy Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Ranbaxy Laboratories
3 dated milestones of Ranbaxy Laboratories across 53 years, from founding to its latest funding, stage changes and deals.
- Founded Ranbaxy Laboratories is founded.
- Funding First funding round of $373K.
- Exit Acquired by Sun Pharma.
Web traffic of Ranbaxy Laboratories
Websites that share an audience with Ranbaxy Laboratories (ranbaxy.com).
Websites whose visitors overlap most with Ranbaxy Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cipla.com | 100% | 200.9K | #203,362 | View details | |
| drreddys.com | 92% | 118.8K | #308,607 | View details | |
| sunpharma.com | 87% | 216K | #177,160 | View details | |
| bms.com | 68% | 809.8K | #67,210 | View details | |
| gsk.com | 68% | 1.3M | #56,834 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Ranbaxy Laboratories
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
10 companies that operate in the same segment as Ranbaxy Laboratories (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ranbaxy Laboratories
Complete news archive for Ranbaxy Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Articles about Ranbaxy Laboratories on our blog
- Top 5 Pharma Companies in India-202126 Feb 2021
Frequently Asked Questions about Ranbaxy Laboratories
Ranbaxy Laboratories was founded in 1961 and raised its 1st funding round 47 years after it was founded.
Ranbaxy Laboratories is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Ranbaxy Laboratories has 1 employees.
The primary company behind Ranbaxy Laboratories, Ranbaxy Laboratories Ltd, reported revenue of ₹1.3 Lakh for FY 2014, up 5% year on year.
Ranbaxy Laboratories was founded in 1961 and operates in the pharmaceutical sector from Gurugram, India. Generic medicines, branded generics, active pharmaceutical ingredients, and intermediates are produced across manufacturing facilities in 11 countries. Operations extend to 49 countries with customer reach in about 125 nations, covering chronic and acute therapeutic areas. Research and development efforts focus on novel drug delivery systems and new chemical entities for infectious, metabolic, and oncology segments.
Ranbaxy Laboratories has 2 investors. Key investors include Sun Pharma, and Department of Biotechnology.
Ranbaxy Laboratories operates through Ranbaxy Laboratories Ltd.
Yes. Ranbaxy Laboratories was acquired by Sun Pharma in April 2014.
The legal entities of Ranbaxy Laboratories currently have 9 directors, including Rajesh Viren Shah, Akihiro Watanabe, Arun Sawhney and others.